Prodrugs-Current and Future Drug Development Strategy
Journal Title: International Journal of Medical and Pharmaceutical Case Reports - Year 2014, Vol 1, Issue 2
Abstract
The focus of traditional prodrug approach was on altering various physiochemical parameters, whereas the current modern computational approach considers designing prodrugs through attaching appropriate linkers with drugs having poor bioavailability which upon exposure to physiological environments release the parent active drugs in a programmable (controlled) manner resulting in an improvement of their bioavailability. With the possibility of designing prodrugs with different linkers, the release rate of the parent active drugs can be controlled. The future of prodrug technology is exciting and yet challenging. Advances must be made in understanding the chemistry of many organic reactions that can be effectively utilized to enable the development of more types of prodrugs. The understanding of organic reaction mechanisms of certain processes, particularly intramolecular reactions, will be the next major milestone in this field. It is envisioned that the future of prodrug technology holds the ability to create safe and efficacious delivery of a wide range of active small molecules and biotherapeutics. This goal can be achieved using computational chemistry methods such as ab initio, semi-empirical and density functional theory (DFT), and molecular mechanics (MM) to calculate physicochemical and molecular properties of current marketed drugs suffer low bioavailability or/and unpleasant taste or odor.
Authors and Affiliations
Rafik Karaman
Keywords
Related Articles
- EP ID EP343872
- DOI 10.9734/IJMPCR/2014/13183
- Views 92
- Downloads 0
Seven Year Survival After Multiple Recurrences and Repeated Metastasectomies with Targeted Therapies for Renal Cell Carcinoma
Background: In spite of resistance and limited response to chemotherapy, radiotherapy and immunotherapy, recent advances led to several targeted agents that showed the prolongation of progressive free survival. Due to th...
Use of Human Embryonic Stem Cells (hESCs) in the Treatment of Glaucoma
Glaucoma is a degenerative, optic neuropathy that results in damage to the optic nerve due to increased intraocular pressure (IOP). IOP can be influenced by hypertension, body mass index, atherosclerotic disease and diab...
Paradoxical Lymphadenopathy after Successful Treatment of Tuberculous Pleuritis
Tuberculous lymphadenopathy can paradoxically increase in size after initial clinical improvement. This paradoxical reaction during tuberculosis treatment is more common among HIV positive than non-HIV patients. However...
Kikuchi - Fujimoto Disease Presenting with Abnormal Liver Function Test Results: Case Report
Kikuchi - Fujimoto disease (KFD) also called histiocytic necrotizing lymphadenitis, characterized by lymphadenopathy (0.5-4 cm) and pain for 1-3 weeks. It mainly occurs in the posterior cervical triangle of the neck. The...
Sickle Cell Thalassemia: A Case Report and Review of Literature
Sickle cell disease is a single gene disorder causing a debilitating systemic syndrome characterized by chronic anaemia, acute painful episodes, organ infarction and chronic organ damage and by a significant reduction in...